Lumida
/NHC
⌘K
National Healthcare Corp

National Healthcare Corp

NHC
$224.47USD-0.20%-0.45 today

MARKET CAP

3.5B

P/E (TTM)

28.6x

FWD P/E

DAY RANGE

$223 – $228

52W RANGE

$114
$239

AI Summary

Stalk
StalkMedium

Stalk for a pullback entry as the primary bullish trend remains intact but short-term timing is unfavorable; medium-term bias is bullish, reinforced by higher highs and higher lows, awaiting acceptance at the rising 50-day SMA near prior support levels.

  • Q2 revenue $408M and EPS $1.74 demonstrate robust growth.
  • Annualized dividend $2.68 yields 1.2%, underlining payout consistency.
  • Rising operating costs pressure profit margins, risking margin compression.
Full analysis →

Buying

7

institutions

Selling

5

institutions

New Positions

4

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY1.98 M417.60 M+80.53 K+38.0%0.01%
RT

Renaissance Technologies LLC

Q2 2026

SELL299.72 K63.35 M+-35.80 K+18.2%0.09%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUYNEW107.25 K22.67 M+107.25 K+0.0%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL36.65 K7.69 M+-34.22 K-33.2%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL27.11 K5.73 M+-3.12 K+18.7%0.00%
EP

Eversept Partners, LP

Q2 2026

BUYNEW22.12 K4.67 M+22.12 K+0.0%0.24%
CA

Citadel Advisors LLC

Q2 2026

SELL9.70 K2.05 M+-10.84 K-37.5%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW9.28 K1.96 M+9.28 K+0.0%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY12.19 K1.95 M+6.10 K+133.8%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW1.86 K393.98 K+1.86 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY131.0027.69 K+130.00+17205.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-4.18 K-100.0%0.00%